[Other] VEXAS syndrome and immune-mediated rheumatic diseases: overlaps in clinical features and mechanisms |
|
This post will be closed automatically in 2026-06-21 20:15
Reward30points
|
20
A randomized phase 2 study of ipilimumab, nivolumab, and brentuximab vedotin in patients with relapsed Hodgkin lymphoma
20
Does board diversity mitigate firm risk-taking? Empirical evidence from China
20
Bearing Capacity of Roads, Railways and Airfields
100
Unilateral pallidotomy in the treatment of cervical dystonia: a retrospective observational study
20
Process efficiency enhancement of single mixed refrigerant LNG process
